Who is eligible for clinical trial NCT06090747?

Participants must meet protocol criteria for Breast Neoplasm. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06090747 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2023-10-13

Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program. (NCT06090747)

🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: Instituto Nacional de Cancerologia de Mexico

🩺 Plain-English Summary (8th-Grade Level)

Breast cancer is the leading cause of mortality in women worldwide. Latin-American women are diagnosed at younger ages, in advanced stages, and with aggressive molecular subtypes. Lifestyle seems related to these aggressive conditions and worse outcomes. The present study seeks to evaluate the effect of a hybrid multidisciplinary intervention for implementing a healthy lifestyle to modify the personal and internal exposome of young women with breast cancer. This randomized controlled experimental study with two groups: Group 1: Hybrid multidisciplinary lifestyle education intervention. Group 2: Individualized hybrid multidisciplinary lifestyle interventions. The multidisciplinary lifestyle intervention program includes oncology, nutrition, physiotherapy, and psychology interventions.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (9 items).

Location: Dr. Marlid Cruz Ramos — México

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Women diagnosed with stage I-III BC, confirmed by pathology and image at the INCAN
Candidates for multidisciplinary treatment including surgery, chemotherapy, and/or hormonal treatments.
Signed the informed consent form
Have access to a mobile phone or any electronic device with an active internet connection to receive the program information.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Patients with inflammatory cancer
Those with cardiomyopathy or ventricular dysfunction (NYHA \>II), arrythmia secondary to left ventricular ejection alterations that requires medication, previous myocardial infarction, or angina pectoris in the last six months
Receiving treatment for cardiovascular or cerebrovascular disease, inflammatory bowel disease, malabsorption syndrome, rheumatoid arthritis, lupus, thyroid diseases, or Cushing syndrome
Unable to walk for at least 1 km
Have cardiovascular, respiratory, or musculoskeletal diseases that impede physical activity
Pregnant or breastfeeding
Have psychiatric conditions impeding active participation in this protocol
Do not understand Spanish

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Dr. Marlid Cruz Ramos — México,

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗